Ioannis Legakis

Ioannis Legakis

Auto-generated profile, based on publicly available information

Ioannis Legakis

Department of Endocrinology and Metabolism, Henry Dunant Hospital, Athens, Greece

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2007 in Hormone and Metabolic Research
Verified
Journal Article
Closed access
PDF file
ILI. N. Legakis
I. N. Legakis
TMT. Mantzouridis
T. Mantzouridis
TMT. Mountokalakis
T. Mountokalakis
Galanin has been found in increased amounts in subjects with type 2 diabetes. The purpose of the present study was to determine the levels of galanin in healthy volunteers during an oral glucose tolerance test (OGTT). We enrolled 11 healthy volunteers, 4 males aged 48±3.56 years with BMI 27±0.5 kg/m2 and 7 females aged 41.3±3.05 years with BMI 27.6±0.9 kg/m2. All were in good health without cardiac, hepatic, renal or other chronic disease. None were taking any medication affecting glucose tolerance (β-blockers, thiazide diuretics, and corticoids) and none had a first degree relative with type 2 diabetes. Glucose tolerance was determined by using the International Expert Committee criteria. Blood samples were collected at 0, 30, 60, 90, 120 and 180 minutes for the measurement of plasma glucose, insulin, C-peptide and human galanin (hGal). During the OGTT, hGal exhibited a significant increase from time 0 to 90 minutes (p < 0.001) and returned to the basal values at 180 minutes, while a positive correlation of blood glucose with hGal was observed during the time scale of OGTT. A significant increase was detected both in insulin and C-peptide from the early beginning of the test at 30 minutes, which remained steady until 90 minutes, and returned gradually to the basal values at 180 minutes. No relationship was found either between hGal and serum insulin, or between hGal and serum C-peptide among the healthy subjects, during the OGTT.

1 February 2004 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
ILI. N. Legakis
I. N. Legakis
TMT. Mantzouridis
T. Mantzouridis
ASA. Saramantis
A. Saramantis
ELE. Lakka-Papadodima
E. Lakka-Papadodima

1 February 2016 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
ILIoannis Legakis
Ioannis Legakis
TMTimos Mantzouridis
Timos Mantzouridis
GBGeorge Bouboulis
George Bouboulis
GCGeorge P. Chrousos
George P. Chrousos
In order to elucidate the interrelationship of adipokines in glucose hemiostasis, we determined the concentration of visfatin and adipsin in blood samples in patients with type 2 diabetes and age-matched controls after an overnight fast. We enrolled 37 patients with known type 2 diabetes -21 males and 16 females, aged 62.95 ± 15.72 years and 43 controls- 28 males and 15 females, aged 60.79 ± 12.67 years. Blood samples were collected after an overnight fast and routine biochemical parameters such as glucose, cholesterol, HDL, LDL, triglycerides along with Hb1Ac, insulin and c-peptide, in addition to circulating visfatin and adipsin were determined in all samples. Data were considered significant at a level of p < 0.05. In patients with type 2 diabetes, circulating adipsin levels were decreased and inversely related with glucose levels while circulating visfatin was increased significantly in the fasting state. These results implicate the adipokines adipsin and visfatin as possible participants in the pathogenesis of type 2 diabetes.

11 October 2023 in Hormone and Metabolic Research
Verified
Journal Article
Closed access
PDF file
ILIoannis Legakis
Ioannis Legakis
GCGeorge P. Chrousos
George P. Chrousos
SCStylianos Chatzipanagiotou
Stylianos Chatzipanagiotou
The human microbiome plays an integral role in health. In particular, it is important for the development, differentiation, and maturation of the immune system, 70% of which resides in the intestinal mucosa. Microbiome studies conducted to date have revealed an association between disturbances in the microbiota (dysbiosis) and various pathological disorders, including changes in host immune status. Autoimmune thyroid diseases are one of the most common organ-specific autoimmune disorders, with a worldwide prevalence higher than 5%. The predominant autoimmune thyroid diseases are Hashimoto’s thyroiditis and Grave’s disease. Several factors, such as genetic and environmental ones, have been studied. In accordance with recent studies, it is assumed that the gut microbiome might play a significant role in triggering autoimmune diseases of the thyroid gland. However, the exact etiology has not yet been elucidated. The present review aims to describe the work carried out so far regarding the role of gut microflora in the pathogenesis of autoimmune thyroid diseases and its involvement in the appearance of benign nodules and papillary thyroid cancer. It appears that future work is needed to elucidate more precisely the mechanism for gut microbiota involvement in the development of autoimmune thyroid diseases.

1 September 1998 in Hormone and Metabolic Research
Verified
Journal Article
Closed access
ILI. Legakis
I. Legakis
ASA. Saramantis
A. Saramantis
DVDionysios Voros
Dionysios Voros
GCG. Chalevelakis
G. Chalevelakis
GTG. Tolis
G. Tolis
The function of the hypothalamic-pituitary-adrenal axis as related to the degree of severity of a septic process was assessed by measuring plasma levels of β-endorphin, ACTH and cortisol. Sixty-one cases of postoperative patients treated at the intensive care unit were classified into four groups according to the severity of infection: Group 1 (control) included patients who did not show any sign of infection, group 2 patients with sepsis, group 3 patients with septic syndrome and group 4 patients with septic shock. Compared to G1 patients' ACTH values (4.16 ± 2.6 pg/ml), a statistically significant increase in ACTH values in various stages of septicemia (p < 0.005) with a noticeable difference also between G3 (7.11 ± 3.7 pg/ml) and G4 (11.5 ± 6.6 pg/ml) (p < 0.05) was found. Differences were also observed in β-endorphin (with a level of significance between the several groups of p = 0.0001). Also, β-endorphin values in G4 (40.6 ± 30.3 pg/ml) differed significantly from each of G1 (17.5 ± 6.6 pg/ml), G2 (21.1 ± 11.3 pg/ml) and G3 (23.5 ± 12 pg/ml) (p < 0.05). A progressive hypercortisolemia was obvious, with values of G4 (37.2 ± 15.6 µg/dl) differing significantly from those of G1 (18 ± 4.6 µg/dl) and G2 (24 ± 8.4 µg/dl) (p < 0.05) and of G3 (28.5 ± 12.3 µg/dl) from that of G1 (p < 0.05). Interestingly, a dissociation of ACTH, β-endorphin and cortisol was observed, in that the increased values of β-endorphin and cortisol, detected in the G3 were not associated with a parallel increase in ACTH. These findings might be interpreted in the sense of an impairment of the stress stimulation of the hypothalamic pituitary adrenal axis. Provided that such a situation can be lethal, our results further confirm the idea that a low-dose, steroid replacement might be beneficial to critical illness.

31 August 2009 in Experimental Diabetes Research
Verified
Journal Article
Open access
PDF file
ILIoannis Legakis
Ioannis Legakis
TMTimos Mantzouridis
Timos Mantzouridis
Type 2 diabetes is characterized by hyperglycemia resulting from insulin resistance in the setting of inadequate beta-cell compensation. Recent studies indicate that for attaining a well-functioning -cell mass, parathyroid hormone-related protein (PTHrP) is a very promising candidate among several insulinotropic peptides. In order to elucidate its role, we determine the levels of PTHrP, insulin and c-peptide in type 2 diabetics and in normal subjects in the fasting state. We enrolled 28 patients (16 men and 12 postmenopausal women) with type 2 diabetes and twenty eight aged-matched healthy individuals as control subjects (15 men and 13 women). PTHrP was statistically significant correlated with glucose in type 2 diabetes and in normal subjects in the fasting state. Additionally, PTHrP serum levels exhibited a significant increase in type 2 diabetes compared to control subjects. Interestingly, PTHrP showed a positive correlation with insulin levels only among healthy individuals presumably due to defective glucose stimulated insulin secretion known to occur in type 2 diabetics. In conclusion ,the strong positive relation of PTHrP with glucose in the fasting state in patients with type 2 diabetes mellitus raises several questions for further experimentation concerning its exact role and physiological significance.